| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/30/1998 | US5773274 Polypeptides and dna molecules |
| 06/30/1998 | US5773268 Chromosome 21 gene marker, compositions and methods using same |
| 06/30/1998 | US5773260 Ribozyme compositions and expression vectors |
| 06/30/1998 | US5773252 Fibroblast growth factor 15 |
| 06/30/1998 | US5773230 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 06/30/1998 | US5772995 Compositions and methods for enhanced tumor cell immunity in vivo |
| 06/30/1998 | US5772993 Osteocalcin promoter-based toxic gene therapy for the treatment of calcified tumors and tissues |
| 06/30/1998 | CA1339935C Dna and rna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes |
| 06/25/1998 | WO1998027425A1 Large-scale purification of full length oligonucleotides by solid-liquid affinity extraction |
| 06/25/1998 | WO1998027230A1 Methods and compositions for polypeptide engineering |
| 06/25/1998 | WO1998027217A1 Method for preparing retrovirus vector for gene therapy |
| 06/25/1998 | WO1998027209A1 Polycationic oligomers |
| 06/25/1998 | WO1998027208A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF |
| 06/25/1998 | WO1998027206A2 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES |
| 06/25/1998 | WO1998027200A2 Human and mammalian dna replication origin consensus sequences |
| 06/25/1998 | WO1998021364A3 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 06/25/1998 | WO1998012220A3 Novel tumor proteins |
| 06/25/1998 | WO1998010750A3 Nucleic acid particle delivery |
| 06/25/1998 | CA2589337A1 Methods and compositions for polypeptide engineering |
| 06/25/1998 | CA2275454A1 Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences |
| 06/25/1998 | CA2274319A1 Methods and compositions for polypeptide engineering |
| 06/25/1998 | CA2274306A1 Human and mammalian dna replication origin consensus sequences |
| 06/24/1998 | EP0848758A1 Targeted nucleotide sequence delivery and integration system |
| 06/24/1998 | EP0848757A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 06/24/1998 | EP0848755A1 Vegf-related protein |
| 06/24/1998 | EP0848616A1 Glucocorticoid enhancement of gene expression |
| 06/24/1998 | EP0848615A1 Multi-subtype fiv vaccines |
| 06/24/1998 | EP0658117B1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 06/23/1998 | US5770690 Bax omega protein and methods |
| 06/23/1998 | US5770581 Gene transcription and ionizing radiation: methods and compositions |
| 06/23/1998 | US5770580 Somatic gene therapy to cells associated with fluid spaces |
| 06/23/1998 | US5770449 Vector for integration site independent gene expression in mammalian host cells which permit immunoglobulin gene expression |
| 06/23/1998 | US5770444 Growth differentiation factor-6 |
| 06/23/1998 | US5770442 Comprises a nonnative amino acid sequence which is a protease recognition sequence |
| 06/23/1998 | US5770430 Cellular injury response element and uses thereof |
| 06/23/1998 | US5770398 Vector for integration site independent gene expression in mammalian host cells |
| 06/23/1998 | US5770386 Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent |
| 06/23/1998 | US5770377 Detecting and preventing deactivation of tumor suppressors or anticarcinogenic agents |
| 06/23/1998 | US5770374 Methods for identifying oncogenes and anti-oncogenes |
| 06/23/1998 | US5770366 Melanoma-inhibiting protein |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/18/1998 | WO1998026092A1 Atherothrombotic disorders: mutation in the factor xiii gene |
| 06/18/1998 | WO1998026077A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE β AS MEDICINE |
| 06/18/1998 | WO1998026067A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | WO1998026066A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes |
| 06/18/1998 | WO1998026062A2 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 06/18/1998 | WO1998026061A2 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 06/18/1998 | WO1998026046A2 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 06/18/1998 | WO1998025968A1 Novel forms of class ii mhc transactivator (ciita) |
| 06/18/1998 | WO1998025956A2 Human gtp-binding proteins |
| 06/18/1998 | WO1998025645A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | WO1998025457A1 Composition and method for preserving progenitor cells |
| 06/18/1998 | WO1998018950A3 AAV-DNA helper virus sequences |
| 06/18/1998 | WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd |
| 06/18/1998 | CA2707726A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 06/18/1998 | CA2274837A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | CA2274735A1 Human gtp-binding proteins |
| 06/18/1998 | CA2274728A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | CA2274102A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes |
| 06/17/1998 | EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy |
| 06/17/1998 | EP0848062A2 Aspartic protease ASP1 |
| 06/17/1998 | EP0848061A2 Self-enhancing, pharmacologically controllable expression systems |
| 06/17/1998 | EP0848060A2 Novel human 11CB splice variant |
| 06/17/1998 | EP0847757A1 Medicine comprising hgf gene |
| 06/17/1998 | EP0847272A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 06/17/1998 | EP0448704B1 Osteogenic devices |
| 06/17/1998 | CN1185176A DNA encoding human paplilloma virus type 18 |
| 06/16/1998 | US5767373 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 06/16/1998 | US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide |
| 06/16/1998 | US5767099 Containing lipophilic groups derived from steroids |
| 06/16/1998 | US5767075 Inhibiting protein interactions |
| 06/16/1998 | US5766948 Culturing neuroblast cells in vessel in serum-free basal medium supplemented with basic fibroblast growth factor, wherein surface of vessel allows attachment of cells |
| 06/16/1998 | US5766903 Circular RNA and uses thereof |
| 06/16/1998 | US5766884 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals |
| 06/16/1998 | US5766851 Susceptibility gene for obesity and type II diabetes mellitus |
| 06/16/1998 | US5766585 Infecting bone marrow cells with recombinant retroviral expression vector that contains a polynucleotide sequence coding a biologically active interleukin receptor antagonist protein, injecting into host; antiinflammatory agents |
| 06/11/1998 | WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them |
| 06/11/1998 | WO1998024924A1 Genetic modification of primate hemopoietic repopulating stem cells |
| 06/11/1998 | WO1998024923A1 Inactivation of hiv co-receptors as therapy for hiv infection |
| 06/11/1998 | WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 06/11/1998 | WO1998024921A1 Syndecan enhancer element and its use for targeting gene expression |
| 06/11/1998 | WO1998024916A1 Novel calpaines, production and use thereof |
| 06/11/1998 | WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 06/11/1998 | WO1998024908A1 Human chemokine beta-13 |
| 06/11/1998 | WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 06/11/1998 | WO1998024899A1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 06/11/1998 | WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
| 06/11/1998 | WO1998024892A1 Ve-cadherin promoter and its uses |
| 06/11/1998 | WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/11/1998 | WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans |
| 06/11/1998 | WO1998024797A1 Antisense inhibition of human adhesion molecules |
| 06/11/1998 | WO1998024479A1 Adeno-associated viral vector-mediated delivery of dna to cells of the liver |
| 06/11/1998 | WO1998024472A1 Uses of thioredoxin |
| 06/11/1998 | WO1998024465A1 Wound healing and treatment of fibrosis |
| 06/11/1998 | CA2277580A1 Human chemokine beta-13 |
| 06/11/1998 | CA2274584A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 06/11/1998 | CA2274304A1 Novel calpaines, production and use thereof |
| 06/11/1998 | CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 06/11/1998 | CA2274002A1 Wound healing and treatment of fibrosis |
| 06/11/1998 | CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans |